Top Pharma Companies in India by Market Cap

BSE Sensex 74638.52 220.47 (-0.29%)

Filter

Top Pharma Companies in India as on Sep-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
31	Sun Pharma Advanced Research Company Ltd.	Q V+ PT	6,297 Small Cap	199.05 (1.43%)	4.02	4.83	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
32	One Global Service Provider Ltd.	Q V+ PT	1,056 Small Cap	530.05 (-1.38%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
33	Fischer Medical Ventures Ltd.	Q V PT	2,320 Small Cap	33.29 (1.28%)	77	4.93	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
34	Nephrocare Health Services Ltd.	Q V+ PT	7,478 Small Cap	753.60 (0.28%)	98.35	6.66	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
35	Gufic Biosciences Ltd.	Q V PT	4,368 Small Cap	443 (1.68%)	59.48	6.36	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
36	Astrazeneca Pharma India Ltd.	Q V PT	16,879 Small Cap	6,615.60 (-0.72%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
37	Gaudium IVF and Women Health Ltd.	Q V PT	845 Small Cap	111.50 (-0.67%)	33.4	5.3	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
38	Jagsonpal Pharmaceuticals Ltd.	Q V+ PT	1,504 Small Cap	227.65 (0.26%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
39	Gujarat Kidney And Super Speciality Ltd.	Q V PT	1,432 Small Cap	175.95 (-3.93%)	91.19	5.6	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
40	Krsnaa Diagnostics Ltd.	Q V PT	1,757 Small Cap	570.25 (2.71%)	18.48	1.82	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
41	Fredun Pharmaceuticals Ltd.	Q V+ PT	2,195 Small Cap	1,396 (3.60%)	51.69	7.71	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
42	Anuh Pharma Ltd.	Q V PT	936 Small Cap	94.78 (1.38%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
43	Panacea Biotec Ltd.	Q V+ PT	2,254 Small Cap	383.35 (2.00%)	N/A	2.75	0.55	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
44	Granules India Ltd.	Q V+ PT	23,868 Small Cap	861.35 (-1.61%)	59.27	5.81	2.07	-5.88	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
45	Pfizer Ltd.	Q V PT	18,305 Small Cap	4,020 (-0.47%)	25.13	4.19	2.39	8.89	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
46	Biocon Ltd.	Q V PT	62,743 Mid Cap	391 (-1.01%)	658.88	2.35	2.96	-18.61	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
47	Aarti Drugs Ltd.	Q V PT	3,941 Small Cap	434.65 (-0.21%)	20.79	2.49	3.55	-6.47	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
48	Ambalal Sarabhai Enterprises Ltd.	Q V PT	310 Small Cap	39.24 (1.50%)	21.85	1.83	4.33	3.30	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
49	Wockhardt Ltd.	Q V+ PT	33,911 Small Cap	2,195.75 (0.37%)	86.91	7.06	4.49	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
50	Medicamen Biotech Ltd.	Q V+ PT	448 Small Cap	328.95 (4.63%)	39.38	1.58	5.31	-13.90	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
51	Glaxosmithkline Pharmaceuticals Ltd.	Q V+ PT	48,312 Mid Cap	2,873.05 (0.32%)	45.42	19.25	5.49	17.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
52	Dishman Carbogen Amcis Ltd.	Q V+ PT	2,672 Small Cap	170.90 (0.35%)	165.22	0.4	5.82	-33.01	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
53	Alivus Life Sciences Ltd.	Q V+ PT	17,570 Small Cap	1,395.40 (-0.37%)	28.52	4.93	6.24	6.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
54	Jubilant Pharmova Ltd.	Q V+ PT	16,998 Small Cap	1,055.55 (0.58%)	47.47	2.34	6.31	-7.74	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
55	Alembic Pharmaceuticals Ltd.	Q V+ PT	16,623 Small Cap	843.80 (-0.77%)	24.1	2.86	6.37	-8.79	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
56	Kopran Ltd.	Q V+ PT	1,342 Small Cap	272.15 (-3.85%)	54.75	2.55	6.74	-8.11	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
57	Fermenta Biotech Ltd.	Q V PT	1,400 Small Cap	473.70 (-0.13%)	23.08	3.38	6.85	5.39	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
58	Venus Remedies Ltd.	Q V+ PT	2,125 Small Cap	1,612.10 (1.14%)	18.34	3.1	7.02	18.39	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
59	Piramal Pharma Ltd.	Q V+ PT	27,692 Small Cap	211.95 (-1.26%)	N/A	3.57	7.03	-174.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
60	Laurus Labs Ltd.	Q V+ PT	1,05,645 Mid Cap	2,019 (0.05%)	99.72	19.34	7.19	-2.25	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Anlon Healthcare	28.97	9.73%
Ind-Swift Labs.	409.95	7.44%
Aarti Pharmalabs	893	5.50%
Shukra Pharmaceut.	58.14	5.25%
Kilitch Drugs(India)	213.20	5%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Guj. Kidney & Super	175.95	-3.93%
Kopran	272.15	-3.85%
Kwality Pharma	3,700	-3.57%
Acutaas Chemicals	3,312.70	-3.20%
Concord Biotech	1,544.65	-2.28%

News about Top Pharma Companies in India

Sep, 2026

Fredun Pharmaceuticals acquires 26% stake in Goodman Vetcare

Together, the businesses will focus on expanding the brand’s footprint into new geographies while gradually strengthening its omnichannel capabilities

Sep, 2026

Fredun Pharmaceuticals informs about press release

Fredun Pharmaceuticals has informed that it enclosed press release titled ‘Fredun Pharmaceuticals Acquires 26% Stake in ?300 Crore-Valued Goodman Vetcare Pvt. Ltd., One of India’s Longest-Standing Dedicated Pet Pharmacies’ issued by the company.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

One Global Service Provider informs about corrigendum to AGM notice

In continuation of its intimation dated 5th September, 2026 regarding the Notice convening the 34th Annual General Meeting (‘AGM’) of the Company dated 3rd September, 2026 (‘AGM Notice’), scheduled to be held on Tuesday, 29th September, 2026 at 02:00 PM IST, One Global Service Provider has informed that a Corrigendum to the AGM Notice (‘Corrigendum’) is being sent today, Monday, 21st September, 2026, through email to the Members to whom the AGM Notice has been dispatched. The Corrigendum provides certain clarifications, modifications, and updates to the resolution and explanatory statement of Item No. 10 of the AGM Notice. A copy of the detailed Corrigendum is enclosed. The Corrigendum to the AGM Notice shall form an integral part of the AGM Notice, the AGM Notice shall always be read in conjunction with this Corrigendum. All other contents of the AGM Notice, save and except as modified or supplemented by Corrigendum, shall remain unchanged. The Corrigendum is also available on the website of the Company at www.1gsp.in and on the website of National Securities Depository Services at www.evoting.nsdl.com. The e-voting period commences on Friday, 25th September, 2026 (09.00 AM IST) and ends on Monday, 28th September, 2026 (05.00 PM IST).

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Biocon informs about press release

Biocon has informed that it enclosed the press release titled ‘Biocon’s Pertuzumab Becomes First Biosimilar to Secure EMA CHMP Approval Recommendation Under New Tailored Clinical Approach’. The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Krsnaa Diagnostics informs about updates

Krsnaa Diagnostics has informed regarding the voting results as the outcome of the postal ballot dated September 17, 2026.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Krsnaa Diagnostics informs about voting results of postal ballot and scrutinizer report

With reference to its letter no. KDL/SE/032/2026-27 dated August 18, 2026, Krsnaa Diagnostics has informed that it enclosed the Postal Ballot Notice dated August 13, 2026 (‘Notice’) for seeking approval of the shareholders of the Company on special resolution: Approval for Issuance of up to 16,21,000 Warrants Convertible into Equity Shares of Face Value Rs.5/- each on a Preferential Basis to the Promoter and Promoter Group of the Company. Pursuant to Sections 108, 110 and other applicable provisions, if any, of the Companies Act, 2013 (‘the Act’) read with the Companies (Management and Administration) Rules, 2014, guidelines prescribed by the Ministry of Corporate Affairs through various Circular(s) and the Listing Regulations, as amended from time to time, the Postal Ballot was conducted through remote e-voting process. The remote e-voting process concluded on Thursday, September 17, 2026, at 17:00 Hrs. (IST), post which Dinesh Shivnarayan Birla (Membership No.: FCS-7658, COP: 13029), Practicing Company Secretary and Proprietor of Dinesh Birla & Associates, Company Secretaries, Scrutinizer submitted the Report on the Postal Ballot voting results on September 18, 2026. Based on the Scrutinizer’s Report, the company has informed that the Special Resolution mentioned in the Postal Ballot Notice dated August 13, 2026 has been passed by the Members of the Company with requisite majority on September 17, 2026, i.e., the last date of remote e-voting. In connection with the above, it has enclosed the following: a. Voting results pursuant to Regulation 44(3) of the Listing Regulations and Section 108 of the Act read with the Companies (Management and Administration) Rules, 2014; and b. Scrutinizer's Report dated September 18, 2026 on remote e-voting.

The above information is a part of company’s filings submitted to BSE.

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Take Ltd.	238 Crore
2	Suven Life Sciences Ltd.	9,679 Crore
3	Aster DM Quality Care Ltd.	65,885 Crore
4	Aurobindo Pharma Ltd.	99,828 Crore
5	Ind-Swift Laboratories Ltd.	3,245 Crore
6	Solara Active Pharma Sciences Ltd.	3,574 Crore
7	Hikal Ltd.	2,788 Crore
8	Fabtech Technologies Ltd.	659 Crore
9	Sanofi Consumer Healthcare India Ltd.	9,249 Crore
10	Tarsons Products Ltd.	1,631 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	27,155	57,954	35.89	11.20	24.65	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,959	1,82,738	83.79	20.36	38.34	29.04
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,464	67,169	37.36	6.13	12.46	27.89
Lupin Ltd. (M)	Somewhat Good	2,123	98,070	17.74	4.12	9.82	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,518	44,562	39.27	9.17	26.53	25.35

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	2,019	1,05,645	117
Sai Life Sciences Ltd. (S)	Somewhat Good	1,604	34,003	76.91
Aurobindo Pharma Ltd. (M)	Very Good	1,696	99,828	53.55
Divis Laboratories Ltd. (L)	Very Good	9,405	2,48,664	52.16
Gland Pharma Ltd. (M)	Very Good	2,922	48,875	45.50
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,604	34,003	94.00	13.32	48.48	23.61
Mankind Pharma Ltd. (M)	Very Good	2,464	95,744	46.87	5.69	24.40	18.10
Ajanta Pharma Ltd. (M)	Very Good	3,518	44,562	39.27	9.17	26.53	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,172	1,15,012	25.48	4.27	14.28	13.52
Gland Pharma Ltd. (M)	Very Good	2,922	48,875	43.30	4.60	22.09	13.18

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,604	34,003	94.00	13.32	48.48	39.96
Lupin Ltd. (M)	Somewhat Good	2,123	98,070	17.74	4.12	9.82	32.37
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,464	67,169	37.36	6.13	12.46	22.19
Abbott India Ltd. (M)	Very Good	27,155	57,954	35.89	11.20	24.65	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,214	97,749	30.34	2.56	15.56	15.75

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Fredun Pharmaceuticals acquires 26% stake in Goodman Vetcare

Fredun Pharmaceuticals informs about press release

One Global Service Provider informs about corrigendum to AGM notice

Biocon informs about press release

Krsnaa Diagnostics informs about updates

Krsnaa Diagnostics informs about voting results of postal ballot and scrutinizer report

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?